Internal Medicine, Hematology & Oncology · Marysville, CA
NPI
1871768069
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
618 5th St
Marysville, CA, 95901
Phone (408) 421-2180
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.5M
1,036 prescriptions
Company payments, 2025
$114
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Amandeep Gill prescribed most often to Medicare patients was Lenalidomide, with 103 prescriptions and refills. In total Amandeep Gill wrote 1,036 Medicare prescriptions that cost $4.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lenalidomide Generic | 103 | 103 | 19 | $1.3M |
| Dexamethasone Generic | 85 | 96 | 37 | $1,424 |
| Prednisone Generic | 83 | 111 | 30 | $704 |
| Hydroxyurea Generic | 77 | 187 | 30 | $2,849 |
| Brukinsa Zanubrutinib | 65 | 65 | Under 11 | $830K |
| Xtandi Enzalutamide | 58 | 58 | Under 11 | $658K |
| Acyclovir Generic | 49 | 108 | 21 | $1,146 |
| Ondansetron Hcl Generic | 48 | 48 | 30 | $393 |
| Abiraterone Acetate Generic | 44 | 71 | 11 | $9,958 |
| Prochlorperazine Maleate Generic | 44 | 44 | 27 | $616 |
| Nivestym Filgrastim-Aafi | 42 | 42 | Under 11 | $39K |
| Imatinib Mesylate Generic | 40 | 48 | Under 11 | $2,399 |
| Tagrisso Osimertinib Mesylate | 24 | 24 | Under 11 | $414K |
| Granix Tbo-Filgrastim | 23 | 23 | Under 11 | $11K |
| Sprycel Dasatinib | 18 | 18 | Under 11 | $181K |
Brand drugs: 323 claims; generic drugs: 713 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amandeep Gill $114 ($114 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $32.82.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.